🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this single arm, open label, phase 2 trial, operable patients with stage...
Status
Unknown
Location
Yantai Yuhuangding Hospital
Start Date
2022-08-04
Trial ID
NCT05800756
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
NOAH study confirmed that trastuzumab combined with chemotherapy can signif...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-02-10
Trial ID
NCT05228951
Treatments Being Tested
This is a a multicenter Phase II clinical study investigating efficacy of p...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2023-02-01
Trial ID
NCT07014410
Treatments Being Tested
This is an investigator-initiated randomized controlled, open-label, multic...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-12-20
Trial ID
NCT05638594
Efficacy and Safety of Dalpiciclib Combined with Anti-HER2 Targeted Therapy...
Status
Recruiting
Location
Sun yat-Sen University Cancer Center, Guangzhou, Yuexiu District
Start Date
2026-06-01
Trial ID
NCT07610720
Treatments Being Tested
This is a single-center Ib / II study of triple targeted drug combination (...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2019-05-12
Trial ID
NCT03772353
Treatments Being Tested
This is a phase II trial exploring the maintenance therapy with trastuzumab...
Status
Not Yet Recruiting
Location
Fudan University
Start Date
2025-09-10
Trial ID
NCT07179939